We solve the toughest computational challenges in drug discovery, delivering tangible value for businesses and society.
Our mission is to solve some of the toughest challenges in life sciences, starting with drug discovery. We develop pioneering solutions and deliver services based on computational excellence, that provide tangible value for life sciences companies today while preparing for future technologies.
To help biotech and pharmaceutical companies, we have developed a computational drug discovery platform to improve the quality of the compounds they test in the lab by leveraging proprietary, high-speed, accurate physics-based methods. With bespoke algorithms and cheminformatics expertise, we seek to optimise our customers' drug discovery pipelines.
Explore our collaborative drug discovery services to accelerate your small molecule research.
We believe that the best solutions in the future will be a combination of classical and quantum algorithms, which leads to our dual-focus strategy: advancing both areas by understanding business problems deeply and developing classical as well as quantum algorithms. This enables us to deliver immediate value while pushing the boundaries of what can be done in computing.
While the field is not fully there yet, quantum computing will bring a new technological era, which requires many organisations to start from the beginning—building knowledge and competencies, identifying relevant use cases, creating POCs, and getting hands-on experience with quantum algorithms.
As quantum computing matures, organizations must re-engineer classical methods to seamlessly integrate with quantum advancements, ensuring long-term impact.
We develop cutting-edge tools and offer collaborative drug discovery services that leverage proprietary methods and state-of-the-art tools to help biotech and pharmaceutical companies improve the quality of their compound screening.
We build quantum proof-of-concepts and help companies get started with quantum chemistry services.
Our ground-breaking platform for binding affinity & kinetics calculations enables pharma and biotech companies working with small molecule drug discovery to iterate smarter, save time & money, and de-risk their drug discovery process.
We aim to cultivate a dynamic and flexible working environment that actively encourages initiative, learning and testing new ideas.
We use cutting-edge algorithms when designing our solutions, and based on the latest academic research our team pushes performance even further.
Experience unprecedented computing power at the click of a button – all of our solutions are Cloud-based, and leverage HPC infrastructure to deliver supercomputing-as-a-service when you need it.
Our algorithms are prepared for Quantum Computing, and our APIs will remain the same. No need to worry about Quantum platforms or hardware performance.
